Back

Dynamics of neurotransmitter and extracellular vesicle-derived microRNA landscapes during heroin and methamphetamine withdrawal

Yu, J.; Chen, F.; Xu, Y.; Shi, K.; Zhang, Z.; Peng, Q.; Xie, Z.; Lu, J.; Wu, H.; Ma, Y.; Zou, L.; Zhou, Y.; Chen, C.; Yang, J.; Kuang, Y.; Wang, Y.; Tan, T.; Zhu, M.; Robbins, T. W.; Wang, K.

2021-04-22 psychiatry and clinical psychology
10.1101/2021.04.19.21255653 medRxiv
Show abstract

Circulating miRNAs in small vesicles known as exosomes within blood have been emerging as a new research hotspot in the field of psychiatric disorders. The aim of this work was to characterize the changes in exosomal microRNA profiles, both short-term and long-term, during substance withdrawal using a cross-sectional study design. Using weighted gene co-expression network analysis, a series of known, conserved, and novel exosomal microRNAs were identified as being associated with withdrawal stage and key neurotransmitters GABA, choline, and serotonin. Bioinformatics analyses established that the differences in the miRNA profile target signaling pathways are associated with developmental and intellectual abnormalities. Notably, a set of dysregulated microRNA signatures including hsa-mia-451a and hsa-mir-21a resulted in an AUC of 0.966 and 0.861, respectively, for predicting patients with substance use disorders. Furthermore, hsa-miR-744a-5p was positively correlated with serotonin, and its important role in maintaining neuronal development and function was revealed using an in vitro human induced pluripotent stem cells derived neuronal model. Taken together, these data suggest that the microRNA content of circulating exosomes represent a biomolecular "fingerprint" of the progression of substance withdrawal and may uncover the putative mechanism of how these exosomal microRNAs contribute to central nervous system development and function.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Molecular Psychiatry
282 papers in training set
Top 0.1%
23.5%
2
Brain, Behavior, and Immunity
116 papers in training set
Top 0.1%
10.3%
3
Translational Psychiatry
260 papers in training set
Top 0.6%
8.3%
4
Journal of Neurochemistry
53 papers in training set
Top 0.1%
5.8%
5
Journal of Advanced Research
14 papers in training set
Top 0.1%
5.8%
50% of probability mass above
6
eLife
5828 papers in training set
Top 24%
5.1%
7
Schizophrenia Research
35 papers in training set
Top 0.2%
3.4%
8
Psychiatry Research
41 papers in training set
Top 0.5%
2.6%
9
Journal of Psychiatric Research
32 papers in training set
Top 0.4%
2.2%
10
Scientific Reports
3612 papers in training set
Top 46%
2.2%
11
Acta Neuropsychiatrica
14 papers in training set
Top 0.2%
1.8%
12
Biomedicines
67 papers in training set
Top 0.9%
1.8%
13
Journal of Affective Disorders
92 papers in training set
Top 1%
1.6%
14
European Neuropsychopharmacology
20 papers in training set
Top 0.2%
1.6%
15
Cells
249 papers in training set
Top 4%
1.2%
16
eBioMedicine
183 papers in training set
Top 4%
1.1%
17
International Journal of Molecular Sciences
494 papers in training set
Top 12%
1.0%
18
Advanced Science
286 papers in training set
Top 8%
1.0%
19
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 4%
0.9%
20
Nature Communications
5641 papers in training set
Top 55%
0.9%
21
Clinical and Translational Medicine
31 papers in training set
Top 0.9%
0.6%
22
Frontiers in Genetics
230 papers in training set
Top 6%
0.6%
23
Schizophrenia
21 papers in training set
Top 0.4%
0.6%
24
Progress in Neuro-Psychopharmacology and Biological Psychiatry
48 papers in training set
Top 1%
0.5%
25
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.5%
26
Psychoneuroendocrinology
36 papers in training set
Top 0.6%
0.5%
27
Neuropsychopharmacology
153 papers in training set
Top 3%
0.5%
28
Journal of Neurology, Neurosurgery & Psychiatry
30 papers in training set
Top 0.9%
0.5%